MRC Technology Appoints New Chair

UK medical research charity MRC Technology has appointed Dr. John Stageman as Chair of its Board of Directors, taking over from John Jeans, who was highly praised for his contribution to the growth and success of the charity over the last six years.

Dr. Stageman has a wealth of experience in the pharmaceutical industry and biotechnology research having held international R&D senior management roles at AstraZeneca, from drug discovery through to global clinical development.

Formerly Chair of the HealthTech and Medicines Knowledge Transfer Network for the Technology Strategy Board (TSB) and a Council member of BBSRC, he is Chair of the Major Awards Committee of the Biomedical Catalyst on behalf of the MRC and TSB. He is a lay Governor and Honorary Professor of Life Sciences at the University of Manchester and was awarded the OBE for his services to the UK Biotechnology Industry in 2011.

John Stageman added: “I am delighted to be joining MRCT at this exciting time, as we realise our objective of progressing scientific discoveries into therapeutic treatments. Our next phase will be delivered from a new location, Stevenage Bioscience Catalyst, a move that represents a key stage in MRCT’s development and further strengthens the already thriving collaboration between academia and industry. It is a privilege to be taking the helm from John Jeans and I wish him well in his future endeavours.”